immbio.com
ImmBio | HomeImmBio develops innovative vaccines with broad efficacy against infectious diseases where the medical need is high.
http://www.immbio.com/
ImmBio develops innovative vaccines with broad efficacy against infectious diseases where the medical need is high.
http://www.immbio.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Saturday
LOAD TIME
1.2 seconds
The Babraham Institute
Babraham●●●●●●●●h Campus
Cam●●●dge , Cambs, CB22 3AT
GB
View this contact
The Babraham Institute
The Babraham Institute
Babraham●●●●●●●●h Campus
Cam●●●dge , Cambs, CB22 3AT
GB
View this contact
The Babraham Institute
The Babraham Institute
Babraham●●●●●●●●h Campus
Cam●●●dge , Cambs, CB22 3AT
GB
View this contact
BUY YOUR DOMAIN
17
YEARS
11
MONTHS
20
DAYS
NETWORK SOLUTIONS, LLC.
WHOIS : whois.networksolutions.com
REFERRED : http://networksolutions.com
PAGES IN
THIS WEBSITE
9
SSL
EXTERNAL LINKS
23
SITE IP
94.236.108.218
LOAD TIME
1.208 sec
SCORE
6.2
ImmBio | Home | immbio.com Reviews
https://immbio.com
ImmBio develops innovative vaccines with broad efficacy against infectious diseases where the medical need is high.
immbio.com
ImmBio | Partnering | Partners
http://www.immbio.com/partners/partner-with-us
ImmBio develops innovative vaccines through key partnerships. The company has selected its portfolio to address major unmet healthcare needs and this approach has attracted a number of partnerships with leading vaccine organisations. In addition to its existing pipeline, ImmBio is interested in pursuing new disease targets, where there is a strong rationale based on the company’s technologies. For further information on specific partnership opportunities please contact us at: info@immbio.com.
ImmBio | ImmBio Wins Funding from UK Government-Backed Biomedical Catalyst to Develop PnuBioVax | Press Releases | Media
http://www.immbio.com/media/press-releases/a
ImmBio Wins Funding from UK Government-Backed Biomedical Catalyst to Develop PnuBioVax. ImmBio Wins Funding from UK Government-Backed Biomedical Catalyst to Develop PnuBioVax. Web design by Studio 24.
ImmBio | Vaccines
http://www.immbio.com/vaccines
ImmBio’s portfolio addresses major unmet healthcare needs. ImmBios lead programme is a vaccine against invasive pneumococcal disease, PnuBioVax™ has progressed into clinical development with the recent successful completion of a Phase I Clinical trial. ImmBio is developing next-generation vaccines targeting infectious diseases, based on its proprietary bacteriaI vaccine technology platforms ImmBioVax™. ImmBios proprietary bacterial vaccine platform, ImmBioVax™, utilises a production proce...
ImmBio | Events | Media
http://www.immbio.com/media/conferences
Web design by Studio 24.
ImmBio | Media
http://www.immbio.com/media
Our press releases, upcoming conferences, posters and key publications can be accessed here. PnuBioVax Phase I Clinical trial results. File, 178.46 Kb. Web design by Studio 24.
TOTAL PAGES IN THIS WEBSITE
9
Immunisation throughout life | Vaccines Europe (European Vaccine Manufacturers)
http://www.vaccineseurope.eu/initiatives/immunisation-throughout-life
Vaccines Europe Board & Teams. The EU Vaccine Industry in Figures. Key facts on vaccines. EU regulatory framework for vaccines. Awareness & attitudes. Research & innovation. Value of the industry. News & press releases. Publications & Infographics. An industry for healthy lives. Europe is at the heart of global vaccine research and production. Most of the activities of the major innovative Vaccines Europe members research based-companies are based in the region. The reasons for this might be several and ...
Useful links | Vaccines Europe (European Vaccine Manufacturers)
http://www.vaccineseurope.eu/useful-links
Vaccines Europe Board & Teams. The EU Vaccine Industry in Figures. Key facts on vaccines. EU regulatory framework for vaccines. Awareness & attitudes. Research & innovation. Value of the industry. News & press releases. Publications & Infographics. An industry for healthy lives. Europe is at the heart of global vaccine research and production. Most of the activities of the major innovative Vaccines Europe members research based-companies are based in the region. Key facts on vaccines. How do they work?
Access to vaccines | Vaccines Europe (European Vaccine Manufacturers)
http://www.vaccineseurope.eu/initiatives/access-to-vaccines
Vaccines Europe Board & Teams. The EU Vaccine Industry in Figures. Key facts on vaccines. EU regulatory framework for vaccines. Awareness & attitudes. Research & innovation. Value of the industry. News & press releases. Publications & Infographics. An industry for healthy lives. Europe is at the heart of global vaccine research and production. Most of the activities of the major innovative Vaccines Europe members research based-companies are based in the region. Population access to new vaccines. A retro...
Awareness & attitudes | Vaccines Europe (European Vaccine Manufacturers)
http://www.vaccineseurope.eu/initiatives/awareness-and-attitudes
Vaccines Europe Board & Teams. The EU Vaccine Industry in Figures. Key facts on vaccines. EU regulatory framework for vaccines. Awareness & attitudes. Research & innovation. Value of the industry. News & press releases. Publications & Infographics. An industry for healthy lives. Europe is at the heart of global vaccine research and production. Most of the activities of the major innovative Vaccines Europe members research based-companies are based in the region. Awareness & attitudes. Is an online platfo...
Vaccines Europe Day Public Conference: Investing in Health Through Prevention | Vaccines Europe (European Vaccine Manufacturers)
http://www.vaccineseurope.eu/media-center/events/vaccines-europe-day-public-conference-investing-in-health-through-prevention
Vaccines Europe Board & Teams. The EU Vaccine Industry in Figures. Key facts on vaccines. EU regulatory framework for vaccines. Awareness & attitudes. Research & innovation. Value of the industry. News & press releases. Publications & Infographics. Vaccines Europe (European Vaccine Manufacturers). Vaccines Europe Day Public Conference: Investing in Health Through Prevention. Vaccines Europe Day Public Conference: Investing in Health Through Prevention. Written by Vaccines Europe. Press release and report.
Babraham Bioscience Technologies Ltd - Bioincubator Companies
http://babraham.co.uk/companies/companies.html
The Babraham Research Campus is also home to The Babraham Institute. Babraham Research Campus - Cambridge - UK. Antitope is pioneering a new generation of immunogenicity testing and protein engineering technologies. Their mission is to apply these technologies to create improved non-immunogenic biologics. Biosceptre International (Biosceptre UK Limited). Cambridge Epigenetix (CEGX) is a biosciences company that aims to be the world leading provider of high quality, easy to use epigenetic tools. Their...
CHORD CAPITAL
http://www.chordcapital.co.uk/welcome/news.html
Comply Serve ( www.complyserve.com. In announcing its unaudited interim results for the six months ended 30 June 2013, Sphere Medical Holding plc (AIM: SPHR.L, www.spheremedical.com. Announced the following highlights:. Significant progress made towards obtaining CE Mark for the current generation of Proxima and its subsequent launch into the UK market. Sphere Medical Holding (AIM: SPHR.L, www.spheremedical.com. In addition, Sphere Medical is also collaborating with the Department of Anesthesiology at th...
Media Center | Vaccines Europe (European Vaccine Manufacturers)
http://www.vaccineseurope.eu/media-center
Vaccines Europe Board & Teams. The EU Vaccine Industry in Figures. Key facts on vaccines. EU regulatory framework for vaccines. Awareness & attitudes. Research & innovation. Value of the industry. News & press releases. Publications & Infographics. Vaccines Europe (European Vaccine Manufacturers). Vaccines Europe position paper on Life-long immunisation. Written by Vaccines Europe. Our position paper can be accessed here. ESWI 6th Influenza Conference, Riga, 10-13 September 2017. The European Scientific ...
Babraham Bioscience Technologies Ltd - Bioincubator Companies
http://www.babraham.com/companies/companies.html
The Babraham Research Campus is also home to The Babraham Institute. Babraham Research Campus - Cambridge - UK. Antitope is pioneering a new generation of immunogenicity testing and protein engineering technologies. Their mission is to apply these technologies to create improved non-immunogenic biologics. Biosceptre International (Biosceptre UK Limited). Cambridge Epigenetix (CEGX) is a biosciences company that aims to be the world leading provider of high quality, easy to use epigenetic tools. Their...
TOTAL LINKS TO THIS WEBSITE
23
ImmbiCon Start
STRATO
STRATO
STRATO
Integrated Medical Management
Let Us Help Navigate Your Practice. Integrated Medical Management (IMM) is owned and operated by Trina Reiff. We are a full-fledged independent company servicing the state of Georgia. We have 20 years of medical billing and software experience. IMM has it’s own billing software, or the capability to log into your current practice management system to submit everything from one system. We will customize to your needs. 2015, Integrated Medical Management Web and Logo Design by Crossroadz Marketing Design.
ImmBio | Home
ImmBio is developing next-generation vaccines against serious infectious disease targets, utilising its proprietary technology platforms to directly induce immunity via dendritic cells. ImmBio has an experienced team of scientists and executives based in state of the art facilities at the Babraham Research Campus, Cambridge UK. ImmBio develops innovative vaccines that induce broad immunity against pathogens. PnuBioVax Phase I Clinical trial results. Web design by Studio 24.
Hírek - Immunológiai és Biotechnológiai Intézet
Projekt eredményei és hatásai. Szisztémás autoimmun betegségek laboratóriumi immunológiai diagnosztikai vizsgálatai. Immunológiai és Biotechnológiai Intézet. Projekt eredményei és hatásai. Szisztémás autoimmun betegségek laboratóriumi immunológiai diagnosztikai vizsgálatai. Immunológiai Kiválósági Centrum szemináriumi sorozat. A PTE KK Immunológiai Kiválósági Centruma szemináriumi sorozatot szervez, amelynek előadásaira tisztelettel hívjuk és várjuk az érdeklődőket.
Immbiomed
Studie zu Labor-Testverfahren bei Zöliakie. Die zentralen Faktoren für den Erfolg von Unternehmen sind innovative Angebote und effektives Marketing in relevante Zielgruppen. ImmBiomed unterstützt Arztpraxen und Unternehmen der Diagnostika-Branche bei den Kernprozessen Angebots-Innovation und zielgruppen-fokussiertes Marketing . Dabei stützt sich die Leistung von ImmBioMed auf medizinischen Sachverstand und die Nutzung des Internets in zielführender und kostengünstiger Art und Weise. Unterstützt Firmen, U...
IMMBIS - miesiarki spiralne z dzieżą stałą. Wywrotnice dzieży. Miesiarki cukiernicze oraz piekarnicze z dzieżą wyjezdną.
MIESIARKI SPIRALNE Z DZIEŻĄ STAŁĄ. Miesiarka spiralna IMMBIS 120. Miesiarka spiralna IMMBIS 180. Miesiarka spiralna IMMBIS 250. MIESIARKI SPIRALNE Z DZIEŻĄ WYJEZDNĄ. Miesiarka spiralna IMMBIS 175. Miesiarka spiralna IMMBIS 250. Miesiarka spiralna IMMBIS 340. Części zamienne i akcesoria. Targi BAKEPOL Lublin 2013. W pierwszej połowie wrzesnia firma brała udział w tagrach cukierniczo - piekarniczych. Nasze produkty cieszyły sie ogromnym zainteresowaniem gości. Miesiarka spiralna IMMBIS 120.
::Immobilizare BIZAR:: Laveno Mombello - Lago Maggiore - Vendita e affitto appartamenti, case, ville - EXPO 2015
Immobiliare BIZAR - Agenzia immobiliare - Laveno Mombello - Lago Maggiore - Varese - Vendita ed affitto casa, villa, appartamento - Case EXPO Milano 2015. Immobili in vendita ed affitto, casa in vendita ed affitto Laveno Mombello, Cerro, Leggiuno, Reno, Cittiglio, Castelveccana, PortoValtravaglia, Luino, Ispra, Monvalle, Sangiano. Offre nel campo immobiliare soluzioni che spaziano dalla prestigiosa villa sul Lago Maggiore agli appartamenti turistici. LAGO MAGGIORE , LAVENO E DINTORNI. Appartamenti - Case...
WEB DESIGN GRAPHICS
